(Q51477188)

English

Oral anti-CD3 monoclonal antibody delays diabetes in non-obese diabetic (NOD) mice: effects on pregnancy and offspring--a preliminary report.

scientific article published in July 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Oral anti-CD3 monoclonal antibody delays diabetes in non-obese diabetic (NOD) mice: effects on pregnancy and offspring--a preliminary report. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

gestational diabetes

0 references

0 references

author name string

Wendy C Bevier

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Angelina L Trujillo

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

George B Primbs

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Maia K Bradley

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Lois Jovanovič

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

27

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

480-487

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Immune modulation for prevention of type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Genetic susceptibility to type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

The Environmental Determinants of Diabetes in the Young (TEDDY) Study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Type 1 diabetes as a relapsing-remitting disease?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

A comprehensive review of interventions in the NOD mouse and implications for translation

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

CD3-specific antibody-induced active tolerance: from bench to bedside

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

CD3-specific antibodies: a portal to the treatment of autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

21 January 2018

Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.1204

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21484981

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51477188&oldid=1446565606"